present
still
reliant
tradit
diagnost
tool
use
decad
determin
microbi
etiolog
pneumonia
current
guidelin
manag
communityacquir
pneumonia
adult
typic
recommend
microbiolog
test
larg
restrict
patient
sever
diseas
give
guidanc
judici
use
blood
cultur
sputum
microscopi
cultur
urinari
antigen
test
serolog
guidelin
manag
communityacquir
pneumonia
children
even
restrict
recommend
test
mainli
use
patient
sever
diseas
focu
blood
cultur
detect
respiratori
virus
common
guidelin
cautiou
approach
use
molecular
diagnost
although
may
chang
ongo
review
caution
driven
partli
perceiv
real
lack
commerci
standard
assay
partli
lack
good
data
diagnost
accuraci
also
linger
percept
molecular
diagnost
expens
test
use
restrict
basi
cost
barrier
use
rel
price
molecular
diagnost
actual
fallen
recent
year
inde
mani
molecular
assay
compar
cost
convent
culturebas
method
molecular
method
particularli
welcom
addit
pneumonia
diagnost
toolbox
collect
repres
singl
biggest
recent
advanc
field
exactli
new
polymeras
chain
reaction
pcr
assay
respiratori
pathogen
around
year
widespread
adopt
nucleic
acid
detect
test
nat
diagnost
laboratori
rel
slow
contrast
nat
infecti
diseas
quickli
embrac
laboratori
clinician
major
reason
slow
uptak
accept
respiratori
nat
lack
commerci
assay
situat
chang
rapidli
undoubtedli
spur
recent
outbreak
global
concern
pandem
influenza
middl
east
respiratori
syndrom
mer
ebola
inde
increas
avail
commerci
assay
major
chang
area
sinc
first
start
review
role
molecular
diagnost
pneumonia
year
ago
date
molecular
test
pneumonia
mainli
focus
detect
specif
known
pathogen
nat
nat
sever
advantag
exist
diagnost
tool
potenti
detect
low
level
allknown
pneumonia
pathogen
clinic
specimen
depend
viabil
target
microb
provid
result
within
clinic
relev
time
frame
also
probabl
less
affect
previou
antimicrobi
therapi
culturebas
diagnost
method
wide
varieti
userfriendli
platform
enabl
nat
deploy
laboratori
outsid
specialist
tertiari
referr
center
although
nat
mainli
focus
detect
presenc
particular
microorgan
may
also
provid
addit
inform
data
antimicrobi
resist
strain
type
nat
wide
use
diagnost
laboratori
detect
potenti
pneumonia
pathogen
part
normal
flora
name
respiratori
virus
select
noncolon
bacteria
microb
simpli
detect
presenc
respiratori
sampl
regard
suffici
evid
assign
causat
contrast
nat
bacteria
includ
import
pneumonia
pathogen
struggl
defin
role
outsid
research
laboratori
nat
detect
follow
respiratori
pathogen
establish
role
nat
revolution
diagnosi
viral
respiratori
tract
infect
high
sensit
specif
rapid
turnaround
time
avail
commerci
assay
nat
test
method
choic
respiratori
virus
respiratori
virus
commonli
detect
nat
often
larg
multiplex
panel
includ
influenza
b
virus
respiratori
syncyti
viru
parainfluenza
virus
human
metapneumoviru
human
rhinovirus
enterovirus
adenovirus
human
bocaviru
sever
coronavirus
nat
also
establish
diagnost
tool
detect
sever
acut
respiratori
syndromecoronaviru
merscoronaviru
context
pneumonia
detect
respiratori
viru
upper
respiratori
specimen
nat
regard
suffici
assign
causat
children
adult
howev
assumpt
alway
reliabl
still
debat
exact
role
virus
pathogenesi
pneumonia
includ
human
rhinovirus
human
bocaviru
led
question
wisdom
use
larg
multiplex
nat
panel
firstlin
test
respiratori
pathogen
given
potenti
problem
interpret
posit
result
addit
control
group
use
pneumonia
etiolog
studi
respiratori
virus
often
detect
similar
proport
subject
without
pneumonia
especi
children
find
vari
specif
viru
influenza
b
virus
respiratori
syncyti
viru
human
metapneumoviru
typic
detect
significantli
higher
proport
case
pneumonia
control
mycoplasma
pneumonia
associ
varieti
upper
lower
respiratori
tract
infect
import
caus
pneumonia
frequent
occur
outbreak
nat
wide
regard
method
choic
detect
pneumonia
infect
pneumonia
target
incorpor
alongsid
viral
target
mani
larg
respiratori
multiplex
panel
practic
nat
also
use
pneumonia
outbreak
identif
manag
upper
lower
respiratori
tract
specimen
suitabl
test
nat
posit
result
context
pneumonia
regard
diagnost
asymptomat
carriag
pneumonia
uncommon
chlamydophila
pneumonia
rel
common
caus
communityacquir
pneumonia
geograph
region
typic
associ
sever
diseas
nat
long
use
diagnost
purpos
inde
c
pneumonia
nat
focu
earliest
effort
standard
nat
respiratori
pathogen
perhap
associ
milder
diseas
c
pneumonia
target
prioriti
incorpor
multiplex
respiratori
panel
colon
pneumocysti
jirovecii
common
among
gener
popul
associ
pneumonia
immunocompromis
individu
nat
advantag
tradit
microscopybas
diagnost
tool
detect
p
jirovecii
induc
sputum
bronchoscop
oropharyng
specimen
high
sensit
inde
pcrbase
method
provid
earli
evid
exist
p
jirovecii
colon
use
quantit
method
necessari
order
discrimin
colon
diseas
thu
least
partial
overcom
problem
falseposit
result
although
promis
cutoff
valu
remain
standard
quantit
nat
may
vari
patient
popul
microscopi
cultur
lower
respiratori
sampl
remain
standard
diagnost
tool
tuberculosi
despit
improv
culturebas
method
slow
turnaround
time
laboratori
diagnosi
global
concern
diseas
burden
multidrug
resist
provid
impetu
develop
rapid
test
method
consider
effort
put
develop
nat
mycobacterium
tuberculosi
sever
commerci
assay
wide
avail
interestingli
tuberculosi
unusu
among
infecti
diseas
nat
less
sensit
cultur
possibl
consequ
difficulti
dna
extract
sensit
typic
smearposit
specimen
smearneg
specimen
importantli
small
userfriendli
platform
xpert
mtbrif
assay
develop
extent
success
deploy
mani
resourcepoor
locat
rapid
diagnost
tuberculosi
need
real
success
stori
highlight
achiev
molecular
diagnost
outsid
major
laboratori
nat
establish
test
detect
caus
agent
pertussi
bordetella
pertussi
major
caus
pertussi
human
complic
pneumonia
bordetella
bronchiseptica
bordetella
holmesii
bordetella
parapertussi
occasion
associ
often
milder
pertussislik
ill
nat
sensit
method
detect
b
pertussi
rapid
turnaround
time
invalu
tool
outbreak
manag
main
limit
b
pertussi
nat
specif
particularli
abil
wide
use
assay
also
detect
b
holmesii
gener
consid
fals
posit
result
use
dual
target
assay
advoc
overcom
potenti
problem
limit
molecular
diagnost
test
pneumonia
need
address
order
progress
develop
common
pneumonia
diagnost
test
inabl
obtain
good
qualiti
specimen
lower
respiratori
tract
major
problem
overcom
new
innov
safe
method
specimen
collect
greater
understand
relationship
chang
lung
distant
specimen
pneumonia
secondmajor
limit
nat
inabl
distinguish
pathogen
innoc
bystand
essenc
need
two
piec
inform
first
particular
microorgan
present
clinic
specimen
second
microorgan
present
caus
episod
pneumonia
date
diagnost
effort
focus
almost
exclus
first
question
ignor
second
usual
much
difficult
answer
unless
microorgan
never
present
colon
eg
legionella
spp
effort
use
nat
diagnost
pneumococc
pneumonia
illustr
key
issu
pneumonia
regard
common
caus
pneumonia
age
group
yet
molecular
test
establish
diagnost
role
pneumonia
also
common
nasopharyng
colon
carriag
preval
exceed
among
children
region
world
earlier
pneumococc
pcr
assay
target
pneumolysin
gene
problem
poor
specif
due
detect
close
relat
streptococci
although
falseposit
result
less
like
current
wide
use
target
eg
autolysin
gene
pneumonia
frequent
detect
nat
upper
lower
respiratori
specimen
patient
pneumonia
clinic
implic
posit
result
uncertain
given
rel
high
preval
pneumococc
carriag
test
blood
pneumonia
pcr
promot
altern
approach
potenti
avoid
issu
contamin
among
italian
children
blood
pcr
show
promis
diagnost
invas
pneumococc
diseas
high
specif
howev
popul
posit
result
report
control
particip
suspect
pneumococc
diseas
rais
concern
broader
util
approach
particular
falseposit
result
rel
common
children
develop
countri
pneumococc
carriag
common
consequ
posit
pneumococc
nat
result
alon
usual
enough
diagnos
pneumococc
pneumonia
possibl
except
use
nat
detect
pneumonia
pleural
fluid
anoth
import
limit
current
nat
focu
natur
specif
known
suspect
pneumonia
pathogen
implicit
focu
assumpt
know
full
rang
key
potenti
pathogen
caus
pneumonia
may
well
correct
increas
interest
use
modern
techniqu
next
gener
sequenc
provid
opportun
discov
new
unexpect
pathogen
broader
approach
technolog
may
provid
novel
insight
pneumonia
etiolog
yet
show
ad
advantag
routin
diagnost
tool
major
new
pneumonia
pathogen
uncov
recent
year
key
reason
slow
adopt
respiratori
nat
diagnost
laboratori
lack
commerci
assay
approv
regulatori
bodi
impact
probabl
felt
usa
given
strict
requir
us
fda
level
import
regul
debat
clear
balanc
need
appropri
regul
new
diagnost
avoid
unnecessari
barrier
deploy
use
test
use
molecular
test
legionnair
diseas
good
exampl
assay
regul
impact
diagnost
strategi
despit
nat
diagnost
test
choic
legionnair
diseas
shortag
fdaapprov
assay
sever
limit
use
test
usa
result
continu
use
suboptim
diagnost
underdiagnosi
diseas
moreov
absenc
promin
role
diagnost
algorithm
possibl
led
incorrect
percept
perform
nat
inadequ
hope
increas
experi
test
revers
percept
major
recent
revel
respiratori
medicin
recognit
lung
microbiom
recent
lung
health
regard
steril
use
modern
cultureindepend
techniqu
support
concept
consist
find
evid
bacteria
lower
airway
import
realiz
challeng
tradit
paradigm
pneumonia
pathogenesi
tradit
view
pneumonia
caus
singl
invas
pathogen
normal
steril
site
like
wrong
increas
recognit
bacteria
virus
frequent
interact
caus
pathway
pneumonia
add
addit
complex
frequent
find
polymicrobi
infect
new
paradigm
domin
speci
emerg
lung
ecosystem
pneumonia
uncertain
mechan
bacteri
versu
viral
pneumonia
concept
simplist
consequ
probabl
need
use
sophist
approach
pneumonia
diagnosi
assay
simpli
target
singl
specif
put
pathogen
lot
learn
begin
understand
chang
microbiom
acut
infect
analysi
lung
microbiom
may
provid
insight
pneumonia
etiolog
reveal
novel
marker
pneumonia
prognosi
treatment
guidanc
molecular
diagnost
techniqu
clearli
central
role
metagenom
analys
provid
anoth
opportun
next
gener
sequenc
technolog
molecular
test
mainstream
diagnost
mani
respiratori
infect
although
still
much
learn
use
effect
assist
manag
pneumonia
involv
molecular
diagnost
test
develop
pneumonia
need
look
beyond
simpl
detect
specif
known
pathogen
also
provid
mean
accur
interpret
clinic
signific
posit
result
good
enough
simpli
assess
new
test
measur
analyt
sensit
make
comparison
perform
similar
assay
diagnost
test
must
evalu
properli
follow
good
epidemiolog
principl
new
develop
molecular
diagnost
must
also
cogniz
emerg
inform
lung
microbiom
like
provid
opportun
discoveri
novel
marker
help
guid
pneumonia
manag
recent
expans
number
varieti
commerci
nat
like
continu
lead
greater
uptak
diagnost
laboratori
greater
incorpor
diagnost
test
algorithm
guidelin
manag
pneumonia
provis
even
userfriendli
platform
enabl
deploy
test
laboratori
tradit
use
molecular
diagnost
effort
need
evalu
clinic
applic
microbi
load
measur
purpos
distinguish
pathogen
colon
microorgan
prognost
marker
still
unclear
new
knowledg
lung
microbiom
affect
develop
pneumonia
diagnost
impact
may
profound
time
next
gener
sequenc
becom
standard
tool
diagnost
laboratori
technolog
may
provid
valuabl
insight
lung
microbi
ecolog
health
diseas
greater
understand
pathogenesi
pneumonia
come
shift
away
target
limit
number
put
pneumonia
pathogen
toward
identif
signal
pattern
characterist
differ
etiolog
stage
pneumonia
hope
signal
suffici
diagnost
accuraci
help
guid
pneumonia
manag
identifi
microbi
etiolog
pneumonia
challeng
larg
due
difficulti
obtain
uncontamin
specimen
site
infect
discrimin
colon
microorgan
true
pathogensmolecular
test
particularli
nat
major
advanc
pneumonia
diagnost
recent
yearsalthough
uptak
rel
slow
nat
establish
role
often
diagnost
choic
detect
respiratori
virus
sever
noncolon
bacteria
eg
legionella
speci
contrast
nat
yet
establish
role
sever
import
bacteri
pneumonia
pathogen
eg
pneumonia
also
asymptomat
colon
upper
respiratori
tractfurth
develop
molecular
test
need
focu
method
help
interpret
signific
posit
result
use
quantit
nat
microbi
load
cutoff
shown
promis
one
mean
discrimin
colon
pathogen
microorganismsth
recent
revel
lung
microbiom
exist
new
knowledg
interact
bacteria
virus
chang
tradit
view
pneumonia
pathogenesi
new
diagnost
need
account
new
paradigm
less
focus
detect
specif
known
pathogen
